Ameriprise Financial Inc Anika Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 25,430 shares of ANIK stock, worth $412,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,430
Previous 31,321 18.81%
Holding current value
$412,983
Previous $793,000 20.81%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$24.25 - $28.75 $142,856 - $169,366
-5,891 Reduced 18.81%
25,430 $628,000
Q2 2024

Aug 14, 2024
SELL
$24.57 - $28.47 $201,547 - $233,539
-8,203 Reduced 20.75%
31,321 $793,000
Q1 2024

May 15, 2024
SELL
$21.95 - $26.42 $1.83 Million - $2.21 Million
-83,571 Reduced 67.89%
39,524 $1 Million
Q4 2023

Feb 14, 2024
SELL
$18.47 - $23.3 $2.24 Million - $2.83 Million
-121,418 Reduced 49.66%
123,095 $2.79 Million
Q3 2023

Nov 14, 2023
SELL
$16.98 - $26.1 $815,922 - $1.25 Million
-48,052 Reduced 16.42%
244,513 $4.56 Million
Q2 2023

Aug 14, 2023
BUY
$25.16 - $28.86 $2.12 Million - $2.43 Million
84,364 Added 40.52%
292,565 $7.6 Million
Q1 2023

May 15, 2023
BUY
$25.91 - $32.1 $680,344 - $842,881
26,258 Added 14.43%
208,201 $5.98 Million
Q4 2022

Feb 14, 2023
SELL
$23.85 - $31.91 $224,595 - $300,496
-9,417 Reduced 4.92%
181,943 $5.39 Million
Q3 2022

Nov 14, 2022
SELL
$21.74 - $24.68 $469,431 - $532,915
-21,593 Reduced 10.14%
191,360 $4.56 Million
Q2 2022

Aug 15, 2022
SELL
$20.4 - $25.53 $100,531 - $125,811
-4,928 Reduced 2.26%
212,953 $4.75 Million
Q1 2022

May 16, 2022
SELL
$24.7 - $36.54 $19 Million - $28.1 Million
-769,767 Reduced 77.94%
217,881 $5.47 Million
Q4 2021

Feb 14, 2022
SELL
$35.83 - $45.03 $261,881 - $329,124
-7,309 Reduced 0.73%
987,648 $35.4 Million
Q3 2021

Nov 15, 2021
SELL
$38.75 - $44.47 $85,831 - $98,501
-2,215 Reduced 0.22%
994,957 $42.3 Million
Q2 2021

Aug 16, 2021
SELL
$39.42 - $48.08 $7,213 - $8,798
-183 Reduced 0.02%
997,172 $43.2 Million
Q1 2021

May 17, 2021
SELL
$32.49 - $45.96 $219,404 - $310,367
-6,753 Reduced 0.67%
997,355 $40.7 Million
Q4 2020

Feb 12, 2021
SELL
$32.59 - $45.26 $92,262 - $128,131
-2,831 Reduced 0.28%
1,004,108 $45.4 Million
Q3 2020

Nov 16, 2020
BUY
$32.56 - $38.57 $3.05 Million - $3.61 Million
93,574 Added 10.24%
1,006,939 $35.6 Million
Q2 2020

Aug 14, 2020
BUY
$27.83 - $37.73 $7.49 Million - $10.2 Million
269,074 Added 41.76%
913,365 $34.5 Million
Q1 2020

May 15, 2020
BUY
$22.38 - $54.06 $1.49 Million - $3.59 Million
66,403 Added 11.49%
644,291 $18.6 Million
Q4 2019

Feb 14, 2020
SELL
$51.85 - $73.36 $3.51 Million - $4.97 Million
-67,695 Reduced 10.49%
577,888 $30 Million
Q3 2019

Nov 14, 2019
SELL
$40.05 - $57.47 $14.2 Million - $20.4 Million
-355,496 Reduced 35.51%
645,583 $35.4 Million
Q2 2019

Aug 14, 2019
BUY
$30.3 - $41.14 $10.8 Million - $14.7 Million
356,686 Added 55.35%
1,001,079 $40.7 Million
Q1 2019

May 15, 2019
BUY
$29.37 - $40.49 $12.9 Million - $17.8 Million
438,849 Added 213.51%
644,393 $19.5 Million
Q4 2018

Feb 14, 2019
BUY
$30.16 - $43.0 $141,963 - $202,401
4,707 Added 2.34%
205,544 $6.91 Million
Q3 2018

Nov 14, 2018
BUY
$32.83 - $42.51 $78,824 - $102,066
2,401 Added 1.21%
200,837 $8.47 Million
Q2 2018

Aug 14, 2018
SELL
$28.77 - $48.27 $4.21 Million - $7.06 Million
-146,311 Reduced 42.44%
198,436 $6.35 Million
Q1 2018

May 15, 2018
BUY
$49.22 - $68.43 $11.2 Million - $15.6 Million
228,253 Added 195.94%
344,747 $17.1 Million
Q4 2017

Feb 12, 2018
SELL
$52.14 - $59.94 $141,560 - $162,737
-2,715 Reduced 2.28%
116,494 $6.28 Million
Q3 2017

Nov 07, 2017
BUY
$51.16 - $58.21 $6.1 Million - $6.94 Million
119,209
119,209 $6.91 Million

Others Institutions Holding ANIK

# of Institutions
123
Shares Held
11.5M
Call Options Held
200
Put Options Held
100
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $237M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email